DoD Tuberous Sclerosis Complex Research Program, Clinical Translational Research Award

The summary for the DoD Tuberous Sclerosis Complex Research Program, Clinical Translational Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Tuberous Sclerosis Complex Research Program, Clinical Translational Research Award: The Clinical Translational Research Award supports forward and/or reverse clinical/translational studies that have a reciprocal flow of ideas and information between basic and clinical science and have the potential to improve the diagnosis, prognosis or treatment of TSC. Projects supported by this award mechanism may include studies moving from preclinical to clinical research (including a pilot clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with clinical trials (such as correlative studies) to develop models that recapitulate relevant clinical outcomes for use in translational research. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism can be found in the report of the National Cancer Institute Translational Research Working group (http://clincancerres.aacrjournals.org/content/14/18/5664.full). These pathways are comprehensive and span the entire translational research continuum from bench to bedside to bench.